MedPath

GAVISCON DOUBLE ACTION

Brand Name: GAVISCON DOUBLE ACTION

Generic Name: SODIUM ALGINATE + SODIUM BICARBONATE + CALCIUM CARBONATE

Active
Registration Number

DR-XY43658

Dosage Form

Chewable Tablet

Issuance Date

April 26, 2024

Expiry Date

August 22, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength250 mg/106.5 mg/187.5 mg
PackagingALU/PVC/PE/PVDC (Triplex) Blister Pack x 8's) (Box of 8's and 96's)

Classification

C
Classification
Over-The-Counter (OTC)
P
Pharmacologic
Antacid/ Antireflux agent
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (3)

Complete list of active ingredients in this pharmaceutical product.

SODIUM ALGINATEActive
Monograph: Alginic acid
SODIUM BICARBONATEActive
CALCIUM CARBONATEActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.